about
Identification of proteomic biomarkers of preeclampsia using protein microarray and tandem mass spectrometryMaternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndromeChemokines profiling of patients with preterm birth.Sphingolipids as a new factor in the pathomechanism of preeclampsia - Mass spectrometry analysis.Maternal plasma and amniotic fluid chemokines screening in fetal Down syndromeIncreased Maternal and Cord Blood Betatrophin in Gestational DiabetesBrief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis.Plasma C16-Cer levels are increased in patients with preterm labor.Biomarkers of spontaneous preterm birth: a systematic review of studies using multiplex analysis.SPR imaging biosensor for determination of laminin-5 as a potential cancer marker in biological material.Amniotic fluid calreticulin in pregnancies complicated by the preterm prelabor rupture of membranes.Amniotic fluid prostaglandin E2 in pregnancies complicated by preterm prelabor rupture of the membranes.Profiling of Selected MicroRNAs in Proliferative Eutopic Endometrium of Women with Ovarian Endometriosis.Erratum: MicroRNAs expression profiling of eutopic proliferative endometrium in women with ovarian endometriosis.Ghrelin in gestational diabetes: serum level and mRNA expression in fat and placental tissue.A case of complete hypogonadotropic hypogonadism with a mutation in the gonadotropin-releasing hormone receptor gene.Profiling of selected angiogenesis-related genes in proliferative eutopic endometrium of women with endometriosis.Determination of cathepsins B, D and G concentration in eutopic proliferative endometrium of women with endometriosis by the surface plasmon resonance imaging (SPRI) technique.Polish Gynecological Society Recommendations for Labor Induction.Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes.Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome.Identification of preterm birth based on RQA analysis of electrohysterograms.Angiogenic factor screening in women with mild preeclampsia - New and significant proteins in plasma.Rupture of the cervix during pregnancy after cervical pessary insertion for preventing preterm birth.Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex.Profiling of selected angiogenesis-related genes in serous ovarian cancer patients.Amniotic Fluid Angiogenic and Inflammatory Factor Profiling in Foetal Down Syndrome.Enzymes and adhesion formation.Determination of cathepsin G in endometrial tissue using a surface plasmon resonance imaging biosensor with tailored phosphonic inhibitor.Maternal Plasma Metabolomic Profiles in Spontaneous Preterm Birth: Preliminary Results.Matrix metalloprotenase-9 in acute pyelonephritisTissue inhibitors of matrix metalloproteinase-1 levels are increased in serum of patients with allergic contact dermatitisMatrix metalloproteinase-13 and membrane type-1 matrix metalloproteinase in peritoneal fluid of women with endometriosisCellular-fibronectin and matrix metalloproteinase-9 in patients with strokeDenervation-reinnervation--hypothesis well-founded but not sufficientMatrix metalloproteinases activity and stromal-epithelial interactionsIncreased serum level of membrane type 1-matrix metalloproteinase (MT1-MMP/MMP-14) in patients with breast cancerDevelopment of surface plasmon resonance imaging biosensors for detection of ubiquitin carboxyl-terminal hydrolase L1Serum irisin concentration in women with gestational diabetes
P50
Q28081536-FA29AEB5-CCEB-4C5B-B964-5D0317D5673DQ28547431-66400D66-F7C1-4D3A-8A46-CD6971D6F0AEQ33607334-55D4A1F0-7527-4F8E-9286-40FAAEC94F94Q33707869-D3AE1091-D84F-408F-9E81-07872315011DQ34590578-B1C2796B-3A56-4A25-882A-38095682ECA9Q35675901-CEC08D26-F65E-4D1A-A9F0-6975389E2018Q36706466-9B9E0F25-BFB5-45F3-B00A-2F0522BC5C75Q37153790-75C2350E-0E6A-412D-9D21-78681260FD71Q38866646-149EEED0-DE8D-498B-BF9D-C341ACBE769DQ38924788-8B606D3E-B7C9-45E9-9B21-4779A64B88CDQ39746294-480368EB-3BDA-4C48-A056-8997A8915B65Q40763844-6F45A7D7-73E3-41E8-8C00-EA9CC162752CQ40932818-4AA9C4EE-C45A-452F-A874-380EA772863FQ41766167-BF1E267C-45F8-40B1-84C5-58871A74B59FQ42956314-F610A256-55A3-4A15-B73C-9AFCC0A7ED01Q43152041-F73AF203-1C02-4CAE-8A96-771129BF6506Q44303639-DF654977-1C3D-43CF-8F07-5488B4550899Q44506501-DAFF1AD1-D56E-4CEB-84FC-4D223276B270Q45830412-9C878F65-D58C-4D4D-9D7A-8279960FAD42Q46304221-2ADA96F8-6C5B-4756-AE2C-181AE38FC8E2Q46619098-000DF1F0-D8BC-4737-8C76-5E28916002AAQ47103321-DFADB6FB-9299-45C2-9CB7-787B655DB583Q47330207-346F467B-9F4B-47A8-AEB0-E8F65694B73AQ47432280-C6969374-1BC1-4683-95E1-D18C04128DA4Q48314014-61891181-8418-454E-97B1-A1F17122C460Q50658711-C81D28A4-9F86-414B-9390-687C075F380FQ50873663-862E0BEA-A7DD-4E92-8CB2-9865A5239D55Q50886065-56BDFAA2-6BB8-4B5B-B4E1-4A446D654D1EQ51033731-C5ACF4DA-9DC8-4B80-8C28-79D1E8990EEAQ51508742-8778C404-3E98-4ED1-AC82-806BB217AC0FQ55380571-281081A3-7685-4EB3-91B9-6A9D1C3FBDE1Q75418020-E2FA7B5E-3439-4EA3-9C51-3AC8651C201EQ80603880-02A9B2FE-C406-45F0-98EE-0F0255DC94BAQ81083998-05D5E9A6-48B8-4907-9824-D6541BA9EF76Q81196589-A0F65EA7-C5C3-4C6A-A05B-54241B9DFFF2Q81638336-30BE4DC4-750D-4E9B-9F6B-B69AB4B62F75Q81640427-87B78CCA-24E9-4F04-A6E4-CA5B6FB32154Q84367643-8A268E70-968C-4591-AFED-BF9AA257A09FQ85778245-BF67517B-5850-4582-8FDD-9D2B9E654397Q87924648-8546F673-991E-475C-BEBF-59B80B9F2DB5
P50
description
researcher ORCID ID = 0000-0001-8955-8198
@en
wetenschapper
@nl
name
Piotr Laudanski
@ast
Piotr Laudanski
@en
Piotr Laudanski
@es
Piotr Laudanski
@nl
type
label
Piotr Laudanski
@ast
Piotr Laudanski
@en
Piotr Laudanski
@es
Piotr Laudanski
@nl
prefLabel
Piotr Laudanski
@ast
Piotr Laudanski
@en
Piotr Laudanski
@es
Piotr Laudanski
@nl
P1153
6602537714
P21
P31
P496
0000-0001-8955-8198